The subsequent increase in UA levels inhibits 1-α-hydroxylase, causing a reduction in 1,25(OH)2D levels and a consequent rise in PTH levels, thus creating a vicious cycle between hyperparathyroidism and hyperuricemia. The gene discussed is PTH; the disease is hyperuricemia.